Repligen Corporation (RGEN)
Repligen Statistics
Share Statistics
Repligen has 56.15M shares outstanding. The number of shares has increased by 0.27% in one year.
| Shares Outstanding | 56.15M |
| Shares Change (YoY) | 0.27% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | 53.02M |
| Failed to Deliver (FTD) Shares | 1.66K |
| FTD / Avg. Volume | 0.21% |
Short Selling Information
The latest short interest is 3.54M, so 6.31% of the outstanding shares have been sold short.
| Short Interest | 3.54M |
| Short % of Shares Out | 6.31% |
| Short % of Float | 7.37% |
| Short Ratio (days to cover) | 4.98 |
Valuation Ratios
The PE ratio is -312.91 and the forward PE ratio is 61.77. Repligen's PEG ratio is 1.82.
| PE Ratio | -312.91 |
| Forward PE | 61.77 |
| PS Ratio | 12.58 |
| Forward PS | 6.4 |
| PB Ratio | 4.05 |
| P/FCF Ratio | 56.03 |
| PEG Ratio | 1.82 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Repligen.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.18, with a Debt / Equity ratio of 0.35.
| Current Ratio | 6.18 |
| Quick Ratio | 6.18 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 6.05 |
| Debt / FCF | 4.82 |
| Interest Coverage | -1.69 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $356.83K |
| Profits Per Employee | $-14.35K |
| Employee Count | 1,778 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.52M |
| Effective Tax Rate | 5.63% |
Stock Price Statistics
The stock price has increased by -15.77% in the last 52 weeks. The beta is 1.27, so Repligen's price volatility has been higher than the market average.
| Beta | 1.27 |
| 52-Week Price Change | -15.77% |
| 50-Day Moving Average | 141.41 |
| 200-Day Moving Average | 145.57 |
| Relative Strength Index (RSI) | 56.57 |
| Average Volume (20 Days) | 779.85K |
Income Statement
In the last 12 months, Repligen had revenue of 634.44M and earned -25.51M in profits. Earnings per share was -0.46.
| Revenue | 634.44M |
| Gross Profit | 274.64M |
| Operating Income | -35.11M |
| Net Income | -25.51M |
| EBITDA | 113.34M |
| EBIT | 44.96M |
| Earnings Per Share (EPS) | -0.46 |
Balance Sheet
The company has 757.36M in cash and 686.25M in debt, giving a net cash position of 71.11M.
| Cash & Cash Equivalents | 757.36M |
| Total Debt | 686.25M |
| Net Cash | 71.11M |
| Retained Earnings | 0 |
| Total Assets | 2.83B |
| Working Capital | 657.18M |
Cash Flow
In the last 12 months, operating cash flow was 175.39M and capital expenditures -32.91M, giving a free cash flow of 142.49M.
| Operating Cash Flow | 175.39M |
| Capital Expenditures | -32.91M |
| Free Cash Flow | 142.49M |
| FCF Per Share | 2.57 |
Margins
Gross margin is 43.29%, with operating and profit margins of -5.53% and -4.02%.
| Gross Margin | 43.29% |
| Operating Margin | -5.53% |
| Pretax Margin | -4.26% |
| Profit Margin | -4.02% |
| EBITDA Margin | 17.86% |
| EBIT Margin | -5.53% |
| FCF Margin | 22.46% |
Dividends & Yields
RGEN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for RGEN is $180, which is 27.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $180 |
| Price Target Difference | 27.3% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
Scores
| Altman Z-Score | 6 |
| Piotroski F-Score | 3 |